• Rybelsus
  • Rybelsus photo

Rybelsus® (Semaglutide)

Diabetes, Obesity

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.


Package Price Per tablet Savings Order
3mg × 90 tablets
Free AirMail shipping
QAR 4924.21 QAR 54.71 QAR 656.22 Add to cart
3mg × 60 tablets
Free AirMail shipping
QAR 3501.61 QAR 58.36 QAR 218.68 Add to cart
3mg × 30 tablets
Free AirMail shipping
QAR 1860.14 QAR 62.00 Add to cart
Package Price Per tablet Savings Order
7mg × 90 tablets
Free AirMail shipping
QAR 5909.09 QAR 65.66 QAR 327.93 Add to cart
7mg × 60 tablets
Free AirMail shipping
QAR 4048.76 QAR 67.48 QAR 109.25 Add to cart
7mg × 30 tablets
Free AirMail shipping
QAR 2079.01 QAR 69.30 Add to cart
Package Price Per tablet Savings Order
14mg × 90 tablets
Free AirMail shipping
QAR 7058.12 QAR 78.42 QAR 327.93 Add to cart
14mg × 60 tablets
Free AirMail shipping
QAR 4814.78 QAR 80.25 QAR 109.25 Add to cart
14mg × 30 tablets
Free AirMail shipping
QAR 2462.02 QAR 82.07 Add to cart


Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.


Country, language and currency

Testimonials

  • Yes I have received the product. It came just as you said it would. I'm very pleased with the delivery. I have not tried the product yet but will soon. If it is as good as your delivery I will be most happy and you will have a customer for a very long time. - Thank you